Drug Interaction Report

Buprenorphine and Piperaquine: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Buprenorphine

Belbuca Brixadi Buprenex BuTrans Simbadol Sublocade Zorbium
+

Piperaquine

No brand names on record
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Contraindicated
These should generally not be used together.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 633 documented Buprenorphine interactions, 22 are rated contraindicated — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Buprenorphine and piperaquine can both prolong the QT interval, and using them together is considered a combination to avoid. Tell your pharmacist or doctor about both so they can pick a safer plan or monitor your heart.

These two medicines are not meant to be taken together. Both buprenorphine (a pain and opioid-treatment medicine) and piperaquine (a malaria medicine) can affect your heart's electrical rhythm. This is called QT prolongation. When two drugs that do this are used at the same time, the effect can add up and, in rare cases, lead to a dangerous heartbeat.

Because of this, the combination is listed as one to avoid. The good news is that your care team has plenty of ways to handle this safely. Please don't stop either medicine on your own, but do let your pharmacist or doctor know you take both so they can guide you.

Effect: Additive risk of QT interval prolongation. Both agents independently prolong the QT interval, so co-administration is additive at the pharmacodynamic level (no prodrug or metabolic activation issue here).

  • Direction: Increased QT prolongation / increased torsadogenic risk.
  • Mechanism: Additive delayed cardiac repolarization.
  • Onset: Unspecified; note piperaquine's long half-life means recently used QT-prolonging drugs may still be circulating.
  • Evidence: Theoretical, but severity on file is contraindicated.
  • Management: Avoid concurrent use. If unavoidable, ECG and electrolyte monitoring (K+, Mg2+) and specialist input are warranted.
Onset
unspecified
Evidence
theoretical
Severity
Contraindicated

What happens

An increased risk of QT interval prolongation

Interaction Deep Dive

It is contraindicated to give piperaquine (a medication that prolongs the QT interval) together with other agents known to prolong the QT interval, such as antiarrhythmic drugs. Furthermore, contraindication also applies to the recent use of QT interval prolonging drugs that could still be present in circulation (depending on their half-life) when piperaquine is administered1.

Why it happens (mechanism)

Additive QT interval prolongation

How to manage this interaction

This combination is flagged to be avoided. Here is what typically happens and what you can do:

  • Your care team may choose an alternative medicine for one of the two, or wait until the earlier drug has cleared, since piperaquine stays in the body a long time.
  • If both must be used, they may monitor your heart more closely (such as an ECG) and check your electrolytes.
  • Keep taking your medicines as prescribed and do not stop either one on your own.
  • Tell your pharmacist or prescriber that you take (or recently took) both, and mention any dizziness, fainting, or palpitations right away.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Buprenorphine and Piperaquine together?

Buprenorphine and piperaquine can both prolong the QT interval, and using them together is considered a combination to avoid. Tell your pharmacist or doctor about both so they can pick a safer plan or monitor your heart. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Buprenorphine and Piperaquine interaction?

It is rated contraindicated. These should generally not be used together.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Buprenorphine and Piperaquine interaction managed?

This combination is flagged to be avoided. Here is what typically happens and what you can do: Your care team may choose an alternative medicine for one of the two, or wait until the earlier drug has cleared, since piperaquine stays in the body a long time. If both must be used, they may monitor your heart more closely (such as an ECG) and check your electrolytes. Keep taking your medicines as pre… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Buprenorphine or Piperaquine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: Eurartesim oral film-coated tablets, piperaquine tetraphosphate dihydroartemisinin oral film-coated tablets. Sigma-Tau Industrie Farmaceutiche Riunite S.p.A (per EMA), Rome, Italy, 2012.
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.